New article published: “The T-win® technology: immune-modulating vaccines“

Jul 9, 2018

Copenhagen, Denmark – July 9, 2018: IO Biotech has published an article describing IO Biotech’s proprietary technology platform, T-win®, in “Seminars in Immunopathology”

Other news

IO Biotech Announces Appointment of Devin Smith as General Counsel

IO Biotech Announces Appointment of Devin Smith as General Counsel

IO Biotech Provides Business Update

IO Biotech Provides Business Update